Production (Stage)
AbbVie Inc.
ABBV
$183.26
$0.720.39%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -30.00% | -12.03% | -21.37% | -38.53% | -20.99% |
| Total Depreciation and Amortization | -3.40% | -3.59% | -4.77% | -2.66% | 1.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 126.57% | 38.04% | -29.04% | -19.47% | -45.98% |
| Change in Net Operating Assets | -244.90% | -198.90% | -160.39% | -103.11% | 946.22% |
| Cash from Operations | -27.70% | -17.66% | -35.29% | -27.03% | -6.36% |
| Capital Expenditure | -27.80% | -25.35% | -13.12% | -15.48% | -12.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -13.71% | -1,577.60% | -1,887.42% | -1,098.47% | -966.42% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,725.00% | 7,555.56% | 328.57% | -103.57% | -102.06% |
| Cash from Investing | -7.83% | -936.34% | -1,091.67% | -592,850.00% | -2,466.31% |
| Total Debt Issued | -62.01% | -- | -- | -- | -- |
| Total Debt Repaid | -58.60% | -252.40% | -15.72% | 13.88% | 27.50% |
| Issuance of Common Stock | -40.91% | 18.89% | 16.34% | 15.25% | 21.61% |
| Repurchase of Common Stock | -0.30% | 13.39% | 31.42% | 32.08% | 32.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -4.96% | -4.61% | -4.61% | -4.65% | -4.64% |
| Other Financing Activities | 108.35% | 94.34% | 90.11% | 84.53% | 54.84% |
| Cash from Financing | -8,093.36% | 69.74% | 87.51% | 90.55% | 99.12% |
| Foreign Exchange rate Adjustments | -80.95% | -1,400.00% | -20.00% | 47.37% | 65.57% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -213.53% | -301.77% | -514.43% | 1,736.55% | 1,752.53% |